This presentation is the property of its rightful owner.
Sponsored Links
1 / 69

2553 PowerPoint PPT Presentation


  • 86 Views
  • Uploaded on
  • Presentation posted in: General

Download Presentation

2553

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


2553

2553

12 2553

6


2553

  • 6 .


2553


2553

Estimated epidemiological burden of TB, 2008


2553

Estimated TB incidence rates, 2008


2553

Estimated HIV prevalence in new TB cases, 2008


2553

HIV testing for TB patients, 2008


2553

Number of cases of MDR-TB estimated, notified and expected to be treated, 27 high MDR-TB burden countries and WHO regions.


2553

Notified cases of MDR-TB (2005-2008) and projected numbers of patients to be enrolled on treatment (2009-2010), The numbers under each bar show the number of countries

reporting data.


2553

  • 11.1

  • 8.8

  • 1.3

  • 15%

  • ( MDR) 5


2553

2008

  • Case notified new & relapse 5.7

  • Case detection rate among new smear positive 62%

  • Case detection rate for all TB cases 61%

  • Treatment success 86% in 2007

  • HIV testing among TB 22%

  • CPT and ART for TB/HIV 71%, 32%

  • ICF among PHA 4.1 % IPT 0.2%

  • MDR-TB treated 29%


2553


2553

2008


2553


2553


2553


Quality dots

QualityDOTS

  • Case detection New SS+

  • treatment success

  • ( NM- , retreatment )


2553

(TB case notification) 2546 - 2552

:2552 . (21 2553 )

:


2553

(Case detection rate) 2546 - 2552

:2552 . ( 21 2553)

:


2553

2546 - 2551

(Treatment outcome of New SS+ TB cases registered in Thailand ,2003 -2008

: 21 2553


2553

2546 - 2551

(Unfavorable outcome of New SS+ TB patients registered in Thailand,2003 - 2008

: 21 2553


2553

2546 - 2551

(Treatment outcome of New SS- TB cases registered in Thailand ,2003 -2008

: 21 2553


2553

2546 - 2551

(Treatment outcome of RelapseTB cases registered in Thailand ,2003 -2008

: 21 2553


2553

2546 - 2551

(Treatment outcome of TAF TB cases registered in Thailand ,2003 -2008

: 21 2553


2553

2546 - 2551

(Treatment outcome of TAD TB cases registered in Thailand ,2003 -2008

: 21 2553


Quality dots1

Quality DOTS

  • ( very strong commitment)

  • lab

  • Improve DOT ( non-family DOT)

  • FDC


Tb hiv

TB/HIV

  • ART CPT


2553

2549 -2552

Counseling

CD4-Testing

CD4<250

ARV

HIV-Testing

TB patients

HIV infection

CPT

: 21 2553

2552

2549

2550

2551


2553

Intensified TB finding among newly detected PHAs in Thailand ,2006- 2009

%newly detected PHAs

2549

2550

2551

2552

(2006)

(2007)

(2008)

(2009)

: 21 2553


2553

2549 -2552(1..51- 30..52)

: 21 2553


2553

(ARV)

2549 -2552(1..51- 30..52)

: 21 2553


2553

2549 - 2551

HIV STATUS

2549

2550

2551

: 21 2553


Tb hiv1

TB/HIV

  • national TB/HIV committee

  • IC

    • admission 2 weeks

    • IC . ( GF8 )

    • 31

      ( GF8 )

    • 6 ( TUC )

  • 3 IPT 8

    ( TUC )


Mdr tb

MDR-TB

  • CAT 4

  • MDR-TB

  • 2

  • DST MDR-TB retreatment , on treatment , pre-treatment

  • GLC (Green Light Committee)


2553

Second line 2552

396

74

68

43

39

37

33

36

25

14

15

20

14

:


Tb in prison

TB in prison

  • mobile X-ray

  • (NCCM)


2553

(TB case notification) 2546 2552-2552

3 cohort

2552

: 21 2553


2553

2546 - 2551

: 21 2553


Tb in migrants

TB in migrants


2553

---

(Case Finding Activities in Non-Thai )

: 25-26 2552


Treatment outcome of new m case

(Treatment Outcome of new m+ Case)

2549

2550

792

1,097

:

25 26 2552


2553


Hss laboratory network

HSS : Laboratory network

  • lab. 12 . (GF6)

  • lab. ( GF6 ) ;

  • culture DST guideline

  • Revise criteria for culture and DST workload


2553

HRD

  • MDR-TB , MIFA

  • 3

  • RTC

  • national TB guideline


2553

PPM


2553

Hospitals in Thailand

Public health hospital ~829

(MOPH)

BMA hospital 9

Public hospital 66

(non MOPH)

Academia hospital 11

Private hospital 322

:

:


Ppm evolution

PPM - Evolution

1999

NTP started by BTB and some region, 72 private hospitals (2009)

2004

TUC project, 27 private hospitals

2006

GFATM round 1, 11 private hospitals (2009)

2008

GFATM round 6, 63 private hospitals (2010)


2553

PPM

. 1-12 .

. . .. .

53

PPM

.


2553

ACSM

  • . incentive 600 . + GF8

  • . (GF8)


2553

  • KM

  • Multi-center study 2

    • MDR-TB

    • TB

  • CRCN


2553

2552


Challenges

Challenges

  • Sustain strong political commitment

  • Improve success rate among all sm+ cases for prevent MDR-TB

  • Improve proportion of ART for TB/HIV

  • Systematic implementation of IC & IPT

  • Standard management of MDR-TB and improve R&R system to achieve the targets

  • Collaboration between prison to health services

  • TB control in illegal migrant

  • Effective functional of regional reference lab.

  • Strengthen and sustain PPM ( project to program)

  • Policy-driven research


Conclusion

Conclusion

  • Q-DOTS ,TB/HIV

  • Success .... MDR ?

  • MDR-TB

  • non-Thai

  • Lab

  • PPM GF6

  • (. .)


2550 2552

2550-2552

6 .


2550 2552 trend in case detection rate

2550 2552 (Trend in Case Detection Rate)

Target


2551 2552 trend in sputum conversion rate

2551-2552 (Trend in Sputum Conversion Rate)

Target

56


2553

2551-2552 (Trend in Sputum Conversion Rate)

57


2549 2551 trend in treatment success rate

2549-2551(Trend in Treatment Success Rate)

Target

58


2549 2551 trend in treatment success rate1

2549-2551(Trend in Treatment Success Rate)

59


Hiv tb 2550 2552 trend in hiv testing in tb cases

HIV TB 2550 -2552(Trend in HIV Testing in TB cases)

Target

60


Arv tb hiv 2550 2552 trend in arv receiving in tb hiv

ARV TB/HIV 2550 - 2552(Trend in ARV receiving in TB/HIV)

Target

61


2550 25521

2550 - 2552

62


Mdr tb 2550 2552

MDR - TB 2550 - 2552


2553

: (TB08)


2553

Target 85%

Target 60%

: (TB-HIV01)


2553

: (TB08)


2553

Target 85%

Target 60%

: (TB-HIV01)


Conclusion1

Conclusion

  • Q-DOTS ,TB/HIV

  • MDR-TB

  • Lab (C/S)

  • (.)

  • (PPM)


Thank you for attention

Thank you for attention


  • Login